The headlines sound like a massive victory for the American consumer. The Federal Trade Commission (FTC) just finalized settlements with corporate giants Express Scripts and CVS Caremark, with OptumRx soon to follow. The agency promised these deals would smash out-of-pocket drug costs and bring transparency to a broken system.
Do not buy the hype.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
